homehome Home chatchat Notifications


This AI can tell if you'll have a heart attack in the next 10 years

All it needs is one chest X-ray -- and a lot of training.

Rupendra Brahambhatt
December 7, 2022 @ 11:11 pm

share Share

Heart attacks affect 805,000 people annually in the US, and heart conditions alone are responsible for about 1 in 5 of the total deaths occurring in the country. Many of these cases could be prevented, but studies highlight that even if a person is young and follows a perfectly healthy lifestyle, they can still have a heart attack. Luckily, we may have a new ally in the form of technology.

A team of doctors looking at chest X-rays. Image credits: National Cancer Institute/Unsplash

A team of researchers has created an AI that assesses the risk of you having a heart attack in the next 10 years, just by looking once at your chest X-ray. 

“Our deep learning model offers a potential solution for population-based opportunistic screening of cardiovascular disease risk using existing chest X-ray images,” said Dr. Jakob Weiss, lead researcher, and radiologist at Massachusetts General Hospital.

Current heart attack prediction model

Heart disorders that originate from reduced or blocked blood flow in arteries due to the accumulation of cholesterol and fat in them are called atherosclerotic cardiovascular diseases (ASCVSD). It is one of the major causes of stroke in heart patients. The deep learning model developed by Dr. Weiss and his team detects patterns in X-ray images that are actually linked to heart attacks resulting from ASCVD. 

Generally, if a doctor wants to predict the risk of heart attack for a patient, they employ a statistical model that calculates the ASCVD risk score. This approach involves evaluating cardiac health on the basis of factors like systolic blood pressure, age, hypertension, Type 2 diabetes diagnosis, race, addiction, blood tests, and sex. However, since it may not always be possible to have access to all these records, the researchers consider X-rays to be an ideal singular parameter for calculating heart attack risk. 

“The variables necessary to calculate ASCVD risk are often not available, which makes approaches for population-based screening desirable. The beauty of this (proposed) approach is you only need an X-ray, which is acquired millions of times a day across the world. As chest X-rays are commonly available, our approach may help identify individuals at high risk,” said Dr. Weiss.

How does an AI predict heart attack risk?

The researchers developed and trained an AI called CXR-CVD risk by using 147,497 chest X-rays of 40,643 individuals who were screened for lung, ovarian, and prostate cancer during a clinical trial. They further tested their deep learning model using chest X-rays (CXRs) of 11,430 patients (the average age of these patients was 60) who were potentially at risk of heart disease and might require statin therapy in the near future.  

The researchers also employed the statistical model to calculate the risk of stroke for these patients and compare it with the AI. While they were able to diagnose all the patients using the CXR CVD risk model, only 2,401 patients were tested using the standard statistical approach because data related to various factors (like cholesterol, BP, etc) was not available for all the patients. 

The CXR-CVD model predicted the risk of a heart attack in 1,096 patients for an average follow-up time of 10.3 years. The study mentions that current healthcare guidelines also recommend that a 10-year risk should be calculated for patients so that they could be prescribed an effective statin treatment strategy to avert cardiovascular problems. 

The researchers claimed that during the tests, their AI performed as well as the traditional statistical method. However, they need to conduct a controlled randomized trial to further confirm its efficacy. 

“Based on a single existing chest X-ray image, our deep learning model predicts future major adverse cardiovascular events with similar performance and incremental value to the established clinical standard,” Dr. Weiss notes.

If the CXR-CVD risk model performs well in the upcoming trial. There is no doubt it will change the way we approach heart attack diagnosis forever.

The study was presented at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America.

share Share

A Hidden Staircase in a French Church Just Led Archaeologists Into the Middle Ages

They pulled up a church floor and found a staircase that led to 1500 years of history.

The World’s Largest Camera Is About to Change Astronomy Forever

A new telescope camera promises a 10-year, 3.2-billion-pixel journey through the southern sky.

AI 'Reanimated' a Murder Victim Back to Life to Speak in Court (And Raises Ethical Quandaries)

AI avatars of dead people are teaching courses and testifying in court. Even with the best of intentions, the emerging practice of AI ‘reanimations’ is an ethical quagmire.

This Rare Viking Burial of a Woman and Her Dog Shows That Grief and Love Haven’t Changed in a Thousand Years

The power of loyalty, in this life and the next.

This EV Battery Charges in 18 Seconds and It’s Already Street Legal

RML’s VarEVolt battery is blazing a trail for ultra-fast EV charging and hypercar performance.

This new blood test could find cancerous tumors three years before any symptoms

Imagine catching cancer before symptoms even appear. New research shows we’re closer than ever.

DARPA Just Beamed Power Over 5 Miles Using Lasers and Used It To Make Popcorn

A record-breaking laser beam could redefine how we send power to the world's hardest places.

Why Do Some Birds Sing More at Dawn? It's More About Social Behavior Than The Environment

Study suggests birdsong patterns are driven more by social needs than acoustics.

Nonproducing Oil Wells May Be Emitting 7 Times More Methane Than We Thought

A study measured methane flow from more than 450 nonproducing wells across Canada, but thousands more remain unevaluated.

CAR T Breakthrough Therapy Doubles Survival Time for Deadly Stomach Cancer

Scientists finally figured out a way to take CAR-T cell therapy beyond blood.